Former Vice President · ALX ONCOLOGY HOLDINGS INC (ALXO)

Steffen Pietzke

A named executive officer of ALX ONCOLOGY in every fiscal year CompBrief holds from FY2020 to FY2021. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$104,813

Salary $104,813Stock awards $0

FY2020: $1,562,865

5th of 5 named executive officers at ALX Oncology by FY2021 total.

5 named officers on file for ALX ONCOLOGY, FY2021

Steffen Pietzke’s pay file — $29

  • 2 fiscal years of pay, line by line
  • ALXO’s disclosed peer group of 20 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how ALX ONCOLOGY’s whole pay program stands against its peers

  • ALX ONCOLOGY’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ALXO→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 22, 2022 (DEF 14A).

Free

Get Steffen Pietzke’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Steffen Pietzke compensation by year

ALX ONCOLOGY Summary Compensation Table · all 2 fiscal years held
In US dollars, as ALX ONCOLOGY reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020FY2021
Salary$257,292$104,813
Bonus$150,000$0
Stock awards—$0
Option awards$994,916$0
Non-equity incentive$123,945$0
Pension and deferred compensation—$0
All other—$0
Total$1,562,865$104,813

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: ALX ONCOLOGY HOLDINGS INC DEF 14A filed April 22, 2022, accession 0000950170-22-005982, and prior-year filings. Open the filing on EDGAR.

How this page was built: the ALX ONCOLOGY HOLDINGS INC filed document, accession 0000950170-22-005982. Every figure is read from that document and cited to the page and table it appears in. Filed April 22, 2022.

$1.6M
$105K
FY20
FY21
SalaryBonusNon-equity incentiveOption awards

ALX ONCOLOGY’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Jaume PonsChief Executive Officer and President$10,112,978
Shelly PintoVice President, Finance and Chief Accounting Officer$7,116,319
Peter GarciaChief Financial Officer$4,751,470
Sophia RandolphChief Medical Officer$4,751,470
Steffen Pietzke · this pageFormer Vice President$104,813

The full ALX ONCOLOGY compensation record

free company brief

This page is one person within ALX ONCOLOGY's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the ALX ONCOLOGY proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are ALX ONCOLOGY's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Steffen Pietzke's compensation dossier · One-time report. No refunds.